Breaking Down China Tobacco International (HK) Company Limited Financial Health: Key Insights for Investors

Breaking Down China Tobacco International (HK) Company Limited Financial Health: Key Insights for Investors

HK | Consumer Defensive | Tobacco | HKSE

China Tobacco International (HK) Company Limited (6055.HK) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

China Tobacco International (6055.HK) delivered striking top-line momentum in H1 2025 with revenue of HK$10.32 billion (up 18.5% YoY) and TTM revenue of HK$14.69 billion (up 14.77% YoY), driven by Tobacco Leaf Products import/export and Cigarettes export segments, even as gross profit in H1 slipped 1.8% to HK$946.5 million; investors will want to weigh a TTM net income of HK$916.75 million and EPS of HK$1.33 (P/E 26.01) against an improved ROE of 28.41%, stable leverage (debt-to-equity ~0.99; total debt HK$2.55 billion) and a current ratio of 1.52 with a quick ratio of 0.99 that flags near-term liquidity sensitivity-cash and equivalents stand at HK$1.23 billion while operating FCF is healthy at HK$610.44 million despite -HK$459.99 million in investing outflows-valuation shows market cap of HK$23.85 billion, EV/EBITDA 17.03 and P/B 6.12, and governance efforts plus a 26.7% interim dividend bump underscore management's focus on returns amid risks from narrowing gross margin, lower equity ratio (30.61%), and limited PEG disclosure; read on for the full breakdown of metrics, debt profiles, cash flows, valuation nuances and strategic growth levers that investors need to consider

China Tobacco International Company Limited (6055.HK) - Revenue Analysis

China Tobacco International Company Limited (6055.HK) demonstrated accelerating top-line momentum into 2025, with strong contributions from its Tobacco Leaf Products Import Business, Cigarettes Export Business, and Tobacco Leaf Products Export Business. Key headline figures show sustained growth across annual, half-year, and trailing twelve-month (TTM) measures.
  • H1 2025 revenue: HK$10.32 billion - up 18.5% year-over-year versus H1 2024.
  • TTM ending June 30, 2025: HK$14.69 billion - up 14.77% YoY.
  • Full-year 2024 revenue: HK$13.07 billion - up 10.46% from 2023.
  • Primary growth drivers: Tobacco Leaf Products Import Business, Cigarettes Export Business, Tobacco Leaf Products Export Business.
  • Employees: 307; revenue per employee ≈ HK$47.07 million.
Period Revenue (HK$ billion) YoY Growth
H1 2025 10.32 +18.5%
TTM to 30-Jun-2025 14.69 +14.77%
FY 2024 13.07 +10.46%
Revenue composition and operational implications:
  • Tobacco Leaf Products Import Business: major contributor to recent incremental revenue, reflecting increased sourcing and trading activity.
  • Cigarettes Export Business: sustained demand in overseas markets supported export volumes and pricing.
  • Tobacco Leaf Products Export Business: complemented import flows, improving gross throughput and margin realization.
  • High revenue per employee (~HK$47.07 million) indicates asset-light trading/merchant model with concentrated human capital.
For strategic context and stated organizational priorities that align with revenue strategies, see: Mission Statement, Vision, & Core Values (2026) of China Tobacco International (HK) Company Limited.

China Tobacco International Company Limited (6055.HK) - Profitability Metrics

China Tobacco International Company Limited (6055.HK) shows mixed short-term operating trends alongside stronger profitability ratios in 2024 and the trailing twelve months through June 30, 2025. The following metrics summarize core profitability and expense dynamics investors should track.
  • Gross profit (H1 2025): HK$946.5 million, down 1.8% from HK$964.2 million in H1 2024.
  • Operating expenses (H1 2025): HK$79.5 million, up 6.1% from HK$74.9 million in H1 2024.
  • Net income (TTM ending June 30, 2025): HK$916.75 million.
  • Net profit margin (2024 / TTM): 6.53% (2024), up from 5.1% in 2023.
  • EPS (TTM ending June 30, 2025): HK$1.33; P/E ratio: 26.01.
  • Return on equity (ROE 2024): 28.41%.
Metric Period Value Change vs Prior
Gross Profit H1 2025 HK$946.5M -1.8% vs H1 2024 (HK$964.2M)
Operating Expenses H1 2025 HK$79.5M +6.1% vs H1 2024 (HK$74.9M)
Net Income TTM to 30 Jun 2025 HK$916.75M N/A
Net Profit Margin 2024 6.53% Up from 5.1% in 2023
EPS TTM to 30 Jun 2025 HK$1.33 N/A
P/E Ratio TTM to 30 Jun 2025 26.01 N/A
Return on Equity (ROE) 2024 28.41% Improved vs prior year
  • Implications: modest decline in gross profit and rising operating costs in H1 2025 put short-term pressure on margins, while EPS, improved net profit margin and high ROE point to effective capital deployment and overall profitability.
  • Investor focus areas: margin trend monitoring, cost control (operating expenses), and sustainability of ROE and EPS relative to the P/E multiple.
Mission Statement, Vision, & Core Values (2026) of China Tobacco International (HK) Company Limited.

China Tobacco International Company Limited (6055.HK) - Debt vs. Equity Structure

China Tobacco International's capital structure through the trailing twelve months ended June 30, 2025, shows a company operating with moderate leverage and sufficient coverage for interest obligations. Key balance-sheet figures and leverage ratios illustrate reliance on liabilities while maintaining ability to service debt.
  • Total assets (TTM to 30 Jun 2025): HK$10.00 billion
  • Total liabilities (TTM to 30 Jun 2025): HK$6.30 billion
  • Stockholders' equity (TTM to 30 Jun 2025): HK$3.50 billion
  • Total debt (TTM to 30 Jun 2025): HK$2.55 billion
  • Equity ratio (2024): 30.61% - down from prior period, indicating greater reliance on liabilities
  • Debt-to-equity ratio: 0.99 (2024) - slightly decreased from 1.00 in 2023, signaling a stable leverage position
  • Debt-to-EBITDA: 2.03 - moderate leverage level
  • Interest coverage ratio: 6.68 - adequate ability to meet interest expenses
Metric Value
Total assets (TTM to 30 Jun 2025) HK$10.00 billion
Total liabilities (TTM to 30 Jun 2025) HK$6.30 billion
Stockholders' equity (TTM to 30 Jun 2025) HK$3.50 billion
Total debt (TTM to 30 Jun 2025) HK$2.55 billion
Equity ratio (2024) 30.61%
Debt-to-equity ratio (2024) 0.99
Debt-to-EBITDA 2.03
Interest coverage ratio 6.68
  • Structure interpretation: With equity representing roughly 35% of assets (HK$3.50B of HK$10.00B), liabilities fund the majority of the asset base; total debt is a subset (HK$2.55B) of total liabilities (HK$6.30B).
  • Leverage trend: Debt-to-equity modestly improved from 1.00 to 0.99 year-over-year, showing marginal deleveraging or equity growth relative to debt.
  • Serviceability: Interest coverage of 6.68 and debt/EBITDA of 2.03 indicate manageable debt levels - not highly aggressive but requiring continued cash-flow discipline.
Further company background and context can be found here: China Tobacco International (HK) Company Limited: History, Ownership, Mission, How It Works & Makes Money

China Tobacco International Company Limited (6055.HK) - Liquidity and Solvency

China Tobacco International shows a generally sound short-term liquidity position with some dependency on inventory and investments to meet obligations. Working capital is positive and operating cash generation is strong for the trailing twelve months ending June 30, 2025, while investing and financing activities recorded net outflows.
  • Current ratio: 1.52 - sufficient short-term assets to cover short-term liabilities.
  • Quick ratio: 0.99 - below 1.0 threshold, indicating potential difficulty meeting obligations without liquidating inventory.
  • Cash & cash equivalents (TTM ending 30 Jun 2025): HK$1.23 billion.
  • Short-term investments (TTM ending 30 Jun 2025): HK$2.74 billion.
  • Operating cash flow (TTM ending 30 Jun 2025): HK$629.44 million.
  • Free cash flow (TTM ending 30 Jun 2025): HK$610.44 million.
  • Cash flow from investing activities (TTM ending 30 Jun 2025): -HK$459.99 million.
  • Cash flow from financing activities (TTM ending 30 Jun 2025): -HK$164.01 million.
Metric Value Implication
Current Ratio 1.52 Coverage of short-term liabilities by current assets
Quick Ratio 0.99 Near liquidity shortfall if inventory cannot be converted quickly
Cash & Cash Equivalents HK$1.23 billion Immediate liquidity buffer
Short-term Investments HK$2.74 billion Highly liquid reserves augmenting cash position
Operating Cash Flow (TTM) HK$629.44 million Strong cash generation from operations
Free Cash Flow (TTM) HK$610.44 million Cash available after capital expenditures
Investing Cash Flow (TTM) -HK$459.99 million Net cash outflows to investments (expansion, capex)
Financing Cash Flow (TTM) -HK$164.01 million Net cash outflows to debt repayment/dividends/share buybacks
For further context on corporate direction and capital allocation priorities see: Mission Statement, Vision, & Core Values (2026) of China Tobacco International (HK) Company Limited.

China Tobacco International Company Limited (6055.HK) - Valuation Analysis

This section synthesizes the market's pricing of China Tobacco International Company Limited (6055.HK) using key valuation multiples and enterprise metrics to highlight where value and expectations currently lie.

  • Market capitalization: HK$23.85 billion - snapshot of equity value.
  • Enterprise value (EV): HK$21.41 billion - reflects total firm value (equity + debt - cash).
  • Forward P/E: 25.16 - the market is pricing in modest future earnings growth relative to current profits.
  • PEG: Not available - limited consensus or reliable estimate for expected EPS growth to normalize P/E.
Valuation Metric Value Interpretation
Market Capitalization HK$23.85 billion Equity market value
Enterprise Value (EV) HK$21.41 billion Total firm value used in capital-structure-neutral multiples
Price-to-Sales (P/S) 1.62 Relatively low revenue multiple vs. many consumer staples
Price-to-Book (P/B) 6.12 Market pays a premium over book equity
Price-to-Tangible-Book (P/TBV) 7.06 High valuation relative to tangible equity
EV/EBITDA 17.03 Moderately elevated operating cash-profit multiple
EV/FCF 11.58 Value placed on free-cash-flow generation
Forward P/E 25.16 Market-implied earnings growth priced into current shares
PEG Not available No reliable consensus on expected EPS growth to derive PEG
  • EV vs Market Cap: EV (HK$21.41B) is below market cap (HK$23.85B) - suggests net cash position or low net-debt impact on EV calculation.
  • Multiple profile: Higher P/B and P/TBV (6.12 and 7.06) imply investors pay a premium for intangible assets, brand, distribution or expected profitability beyond tangible assets.
  • Cash-flow emphasis: EV/FCF of 11.58 shows the market values the company's free cash flow generation more attractively than its EBITDA multiple alone would suggest.
  • Growth expectations: Forward P/E of 25.16 signals anticipated earnings improvement; absence of PEG requires digging into consensus EPS growth to contextualize whether P/E is justified.

For further company context and background that complements this valuation lens, see: China Tobacco International (HK) Company Limited: History, Ownership, Mission, How It Works & Makes Money

China Tobacco International Company Limited (6055.HK) - Risk Factors

Investors evaluating China Tobacco International Company Limited (6055.HK) should weigh several measurable financial risks that could affect near‑term liquidity, leverage and profitability.

  • Gross profitability: gross profit margin fell by 1.8% in H1 2025, signaling potential cost‑pressure or pricing challenges.
  • Leverage: equity ratio declined to 30.61% in 2024, indicating greater reliance on liabilities and higher financial leverage.
  • Liquidity: quick ratio of 0.99 implies limited ability to meet short‑term obligations without converting inventory to cash.
  • Cash flows - investing: trailing twelve months to 30 Jun 2025 shows cash flow from investing activities of -HK$459.99 million (net cash outflow).
  • Cash flows - financing: trailing twelve months to 30 Jun 2025 shows cash flow from financing activities of -HK$164.01 million (net cash outflow).
  • Valuation/growth metric gap: PEG ratio not available, restricting insight into expected earnings growth relative to current P/E.
Metric Value Period / Notes
Gross profit margin change -1.8% H1 2025 vs prior comparable period
Equity ratio 30.61% FY 2024
Quick ratio 0.99 Most recent reported
CF from investing activities -HK$459.99 million TTM ending 30 Jun 2025
CF from financing activities -HK$164.01 million TTM ending 30 Jun 2025
PEG ratio Not available No consensus or published forecast-based PEG

Key operational and financial exposures derived from the above metrics:

  • Margin compression could reflect rising production/input costs, unfavorable product mix, or pricing pressure in key markets.
  • Lower equity ratio raises susceptibility to interest rate moves and reduces balance sheet flexibility for acquisitions or CAPEX.
  • Quick ratio <1.0 means near‑term obligations may require inventory liquidation, working capital financing, or use of cash reserves.
  • Negative investing and financing cash flows (‑HK$459.99m and ‑HK$164.01m) point to net capital deployment and deleveraging/repayments; monitor runway and funding strategy.
  • Absence of a PEG ratio complicates assessments that combine valuation and expected growth; investors should use alternative growth forecasts and scenario analyses.

For broader investor context and shareholder activity, see: Exploring China Tobacco International (HK) Company Limited Investor Profile: Who's Buying and Why?

China Tobacco International Company Limited (6055.HK) - Growth Opportunities

China Tobacco International Company Limited (6055.HK) is positioning growth around technology-led efficiencies, capital stewardship, risk management improvements, and human capital development, with explicit shareholder-return signals (notably a 26.7% increase in interim dividend per share announced for H1 2025). The company's strategic initiatives can be grouped into four value-creation pillars:
  • Digital transformation and data-driven decision making
  • Capital and financing optimization
  • Risk prevention and internal controls
  • Employee development, incentives, and retention
Digital transformation and analytics
  • Accelerating digital transformation to improve forecasting accuracy, SKU profitability analysis, and channel-level performance monitoring.
  • Upgrading ERP/BI tools to shorten monthly close cycles and enable near-real-time dashboards for sales, margins, and cash flow.
  • Strengthening analytical and forecasting capabilities to reduce inventory turns variability and improve working-capital efficiency.
Capital management and financing cost control
  • Refined capital management with aims to lower average financing cost via debt mix optimization and proactive cash pooling.
  • Focus on free cash flow conversion and refinancing of short-term facilities where cheaper long-term alternatives exist.
  • Commitment to deliver higher shareholder returns-evidenced by the 26.7% interim dividend per-share increase for H1 2025-indicating disciplined capital allocation and confidence in cash generation.
Internal controls and risk prevention
  • Refinement of internal control mechanisms to close gaps in procurement, inventory reconciliation, and transfer-pricing oversight.
  • Integrated risk dashboards to track liquidity risk, counterparty exposure, and compliance breaches with SLA-based alerts.
  • Emphasis on audit trail digitization to reduce manual error and accelerate issue remediation.
Employee development, incentives and culture
  • Optimizing the employee career development framework to improve talent pipeline and reduce critical-role vacancy time.
  • Implementing mentorship programs and targeted training to lift productivity and cross-functional collaboration.
  • Deepening employee care and refining performance & incentive systems to enhance motivation, retention, and alignment with shareholder value.
Key performance indicators and near-term targets
Area Current Focus Near-term Target
Forecasting accuracy Implement BI/AI models for sales and demand Reduce forecast error by 15-25% vs. baseline
Working capital Inventory & receivables optimization Improve DSO/DIO combination by 10-20%
Average financing cost Debt mix optimization Lower blended interest cost by 50-150 bps
Internal control incidents Strengthen procurement and audit processes Reduce incidents and remediation time by 30%+
Employee retention & development Mentorship, career paths, refined incentives Decrease voluntary turnover among critical roles by 20%
Shareholder returns Dividend policy and capital discipline Progressive dividend increases (H1 2025 interim +26.7%)
Operational levers that translate initiatives into financial impact
  • Pricing optimization via SKU-level margin analytics to protect gross margin.
  • Channel mix shift toward higher-margin outlets and direct channels to improve EBITDA margin.
  • Capital expenditure prioritization-digital and automation projects with sub-3 year payback to elevate ROIC.
  • Refinancing and centralized treasury to reduce interest expense and volatility in net finance cost.
Investor implications and what to watch next
  • Execution on digital and analytic projects-measurable improvements in forecast accuracy and inventory turns will be early signals.
  • Progress in lowering blended financing costs and clear metrics on free-cash-flow generation underpinning dividend sustainability.
  • Published KPIs on internal control incidents and talent retention as leading indicators of operational resilience.
  • Future interim/full-year dividend announcements-continued increases would validate capital-allocation discipline and cash-flow confidence.
Exploring China Tobacco International (HK) Company Limited Investor Profile: Who's Buying and Why?

DCF model

China Tobacco International (HK) Company Limited (6055.HK) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.